The Cooper (LTS:0I3I) FCF Margin % : 0.49% (As of Jan. 2024)

View and export this data going back to 2018. Start your Free Trial

What is The Cooper FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. The Cooper's Free Cash Flow for the three months ended in Jan. 2024 was $5 Mil. The Cooper's Revenue for the three months ended in Jan. 2024 was $932 Mil. Therefore, The Cooper's FCF Margin % for the quarter that ended in Jan. 2024 was 0.49%.

As of today, The Cooper's current FCF Yield % is 0.70%.

The historical rank and industry rank for The Cooper's FCF Margin % or its related term are showing as below:

LTS:0I3I' s FCF Margin % Range Over the Past 10 Years
Min: 3.71 Med: 14.74 Max: 21.8
Current: 3.71

During the past 13 years, the highest FCF Margin % of The Cooper was 21.80%. The lowest was 3.71%. And the median was 14.74%.

LTS:0I3I's FCF Margin % is ranked better than
67.55% of 829 companies
in the Medical Devices & Instruments industry
Industry Median: -7.57 vs LTS:0I3I: 3.71

The Cooper FCF Margin % Historical Data

The historical data trend for The Cooper's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper FCF Margin % Chart

The Cooper Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

FCF Margin %

Get a 7-Day Free Trial

15.87

7.25

17.94

13.61

5.98

The Cooper Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
FCF Margin %	Get a 7-Day Free Trial															9.74	5.77	5.55	3.15	0.49

Competitive Comparison of The Cooper's FCF Margin %

For the Medical Instruments & Supplies subindustry, The Cooper's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Cooper's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's FCF Margin % distribution charts can be found below:

* The bar in red indicates where The Cooper's FCF Margin % falls into.

The Cooper FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

The Cooper's FCF Margin for the fiscal year that ended in Oct. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Oct. 2023 )	/	Revenue (A: Oct. 2023 )
	=	215	/	3593.2
	=	5.98 %

The Cooper's FCF Margin for the quarter that ended in Jan. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jan. 2024 )	/	Revenue (Q: Jan. 2024 )
	=	4.6	/	931.6
	=	0.49 %

The Cooper FCF Margin % Related Terms

Thank you for viewing the detailed overview of The Cooper's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

The Cooper (LTS:0I3I) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (LTS:0I3I) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

COO:USA COO:Mexico CP6:Germany C1OO34:Brazil

Address

6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583

Website

https://www.coopercos.com

The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

The Cooper (LTS:0I3I) Headlines

No Headlines